Medline Inc.
MDLN
$41.46
$0.390.95%
NASDAQ
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/28/2025 | ||
|---|---|---|---|---|---|
| Net Income | -37.02% | -0.62% | 11.58% | 11.58% | |
| Total Depreciation and Amortization | 3.16% | 2.02% | 4.41% | 4.41% | |
| Total Amortization of Deferred Charges | -6.67% | 0.00% | 11.11% | 11.11% | |
| Total Other Non-Cash Items | 8.00% | -38.36% | 128.74% | 128.74% | |
| Change in Net Operating Assets | 58.53% | -98.39% | -780.70% | -780.70% | |
| Cash from Operations | 413.70% | -11.91% | -21.52% | -21.52% | |
| Capital Expenditure | -51.65% | 5.61% | -45.18% | -45.18% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | 100.00% | 100.00% | 102.61% | 102.61% | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -42.27% | 89.88% | 40.95% | 40.95% | |
| Total Debt Issued | -100.00% | 247.20% | -97.65% | -97.65% | |
| Total Debt Repaid | 35.29% | -182.27% | 97.23% | 97.23% | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -196,900.00% | -500.00% | 6.25% | 6.25% | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | 92.94% | -183.33% | -158.97% | -158.97% | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 164.35% | 71.15% | -199.41% | -199.41% | |
| Foreign Exchange rate Adjustments | 50.00% | -50.00% | 350.00% | 350.00% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 163.03% | 144.38% | -68.70% | -68.70% | |